The effect of Ca-antagonists on the release of IL-1.BETA. by human peripheral blood monocytes.
スポンサーリンク
概要
- 論文の詳細を見る
The effects of Ca-antagonists on the release of IL-1β by LPS stimulated human blood monocytes (HBMs) were examined by radioimmunoassay. Caantagonists used were nicardipine, nifedipine, nimodipine, flunarizine, verapamil and diltiazem. Flunarizine strongly inhibited the IL-1β release from HBMs by LPS with an IC<SUB>50</SUB> of 25.9 μM. Diltiazem and verapamile inhibited at the higher concentration (IC<SUB>50</SUB>> 160 μM), but the other Ca-antagonists, dihydropyridine type, such as nicardipine, nifedipine and nimodipine did not affect the IL-1β release from HBMs. In order to investigate the mechanism of IL-1β inhibition of flunarizine, forskolin was used. Forskolin was 2 fold potentiated the IL-1β release from HBMs stimulated by LPS. Flunarizine pretreatment with dose of IC<SUB>50</SUB> completely inhibited IL-1β release from HBMs increased by forskolin.<BR>Taken together, these results suggest that the mechanism of the inhibition of IL-1β release from HBMs by flunarizine may be closely related to cyclic AMP.
- 日本炎症・再生医学会の論文
日本炎症・再生医学会 | 論文
- 新規キノリノン誘導体TA-270の炎症性気道疾患に対する効果
- Salazosulphapyridine, Predonizolone の好中球機能に及ぼす影響と Sodium ferrous citrate との併用効果についての検討
- Sodium ferrous citrate の好中球機能に及ぼす影響
- Mesalazine(Pentasa) の好中球機能に及ぼす影響と Sodium ferrous citrate(SFC) との併用効果についての検討
- 非ウイルスベクターによる細胞標的法の開発